Fenofibrate combined with Humira

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Cerebrovascular Accident Death 1/15/2006 Female 1/20/2006 France
Primary
Concomitant
Nodule Other Serious 4/3/2005 Female 170 lb 5/5/2006 Consumer Canada
Primary
Concomitant
Urinary Tract Infection Hospitalization 6/1/2005 Female 165 lb 5/17/2006 Physician Canada
Primary
Concomitant
Rhabdomyolysis Hospitalization 6/2/2006 Male 159 lb 8/24/2006 Physician United States
Primary
Concomitant
Syncope Other Serious 3/1/2006 Female 12/21/2006 Physician Belgium
Primary
Concomitant
Diverticular Perforation Hospitalization 11/13/2006 Male 1/4/2007 Physician Belgium
Primary
Concomitant
Pancreatitis Hospitalization 11/1/2006 Male 209 lb 3/8/2007 Consumer United States
Primary
Concomitant
Necrosis Hospitalization 2/1/2007 Female 117 lb 5/3/2007 France
Primary
Concomitant
Diverticular Perforation Hospitalization 11/13/2006 Male 5/7/2007 Physician Belgium
Primary
Concomitant
Necrosis Hospitalization 2/1/2007 Female 117 lb 5/16/2007 France
Primary
Concomitant
Cerebrovascular Accident Death 1/15/2006 Female 5/16/2007 France
Primary
Concomitant
Diverticular Perforation Hospitalization 11/13/2006 Male 5/22/2007 Physician Belgium
Primary
Concomitant
Septic Shock Hospitalization 7/17/2007 Female 141 lb 9/7/2007 United Kingdom
Primary
Concomitant
Pulmonary Hypertension Disability 11/21/2006 Female 141 lb 9/12/2007 United Kingdom
Primary
Concomitant
Weight Decreased Other Serious 7/1/2007 Female 158 lb 9/12/2007 Canada
Primary
Concomitant
Pneumonia Other Serious 5/2/2007 Female 10/8/2007 United States
Primary
Concomitant
Oesophageal Rupture Other Serious 3/4/2005 Female 11/5/2007 United States
Primary
Concomitant
Pyrexia Hospitalization 10/29/2007 Female 180 lb 11/12/2007 United States
Primary
Concomitant
Septic Shock Hospitalization 7/17/2007 Female 141 lb 12/5/2007 United Kingdom
Primary
Concomitant
Drug Ineffective 7/24/2007 Female 160 lb 12/14/2007 Consumer United States
Primary
Concomitant
Injection Site Warmth 8/16/2007 Female 152 lb 12/14/2007 Consumer United States
Primary
Concomitant
Vomiting Hospitalization 10/4/2007 Female 12/14/2007 Physician United States
Primary
Concomitant
Chest Pain 9/19/2007 Female 190 lb 12/14/2007 United States
Primary
Concomitant
Urinary Tract Infection 9/19/2007 Female 160 lb 12/14/2007 United States
Primary
Concomitant
Sneezing 10/11/2007 Male 12/14/2007 United States
Primary
Concomitant
Oedema Peripheral 6/1/2007 Female 130 lb 12/14/2007 Pharmacist United States
Primary
Concomitant
Injection Site Pain 11/6/2007 Male 160 lb 12/14/2007 Consumer United States
Primary
Concomitant
Weight Increased 9/1/2007 Male 143 lb 12/14/2007 United States
Primary
Secondary
Concomitant
Panic Attack 10/18/2007 Female 155 lb 12/15/2007 Consumer United States
Primary
Concomitant
Nausea 11/25/2007 Female 156 lb 12/15/2007 United States
Primary
Concomitant
Vomiting Hospitalization 10/4/2007 Female 1/11/2008 Physician United States
Primary
Concomitant
Septic Shock Hospitalization 7/17/2007 Female 141 lb 1/30/2008 United Kingdom
Primary
Concomitant
Skin Necrosis Hospitalization 2/1/2007 Female 117 lb 1/31/2008 France
Primary
Concomitant
Skin Necrosis Hospitalization 2/1/2007 Female 117 lb 3/13/2008 France
Primary
Concomitant
Vasodilatation Hospitalization 1/1/2008 Male 3/14/2008 Physician United States
Primary
Concomitant
Nasopharyngitis 12/12/2007 Female 200 lb 3/14/2008 Consumer United States
Primary
Concomitant
Pain In Extremity 8/19/2007 Female 150 lb 3/14/2008 Consumer United States
Primary
Concomitant
Injection Site Pain 1/10/2008 Female 125 lb 3/15/2008 United States
Primary
Concomitant
Vision Blurred 5/1/2007 Male 240 lb 3/15/2008 United States
Primary
Concomitant
Pneumonia 12/1/2007 Female 351 lb 3/15/2008 United States
Primary
Concomitant
Wrist Fracture 2/6/2008 Female 3/15/2008 Physician United States
Primary
Concomitant
Headache 2/16/2008 Male 3/15/2008 United States
Primary
Concomitant
Supraventricular Tachycardia Life Threatening 2/11/2008 Female 107 lb 4/28/2008 United States
Primary
Concomitant
Respiratory Distress Hospitalization 4/29/2008 Male 260 lb 5/27/2008 Physician United States
Primary
Concomitant
Rash Papular 8/1/2007 Female 150 lb 6/12/2008 Consumer United States
Primary
Concomitant
Feeling Abnormal 3/19/2008 Female 170 lb 6/12/2008 United States
Primary
Concomitant
Rhinorrhoea 8/2/2007 Female 132 lb 6/12/2008 United States
Primary
Concomitant
Throat Irritation 4/12/2008 Female 204 lb 6/12/2008 United States
Primary
Concomitant
Frequent Bowel Movements 4/18/2008 77 Male 6/12/2008 United States
Primary
Concomitant
Herpes Zoster 4/16/2008 Female 210 lb 6/13/2008 United States
Primary
Concomitant
Vision Blurred 5/1/2008 Male 198 lb 6/13/2008 United States
Primary
Concomitant
Somnolence Male 6/13/2008 United States
Primary
Concomitant
Frequent Bowel Movements 4/22/2008 Male 208 lb 6/13/2008 United States
Primary
Concomitant
Pharyngolaryngeal Pain 4/18/2008 Female 140 lb 6/13/2008 United States
Primary
Concomitant
Injection Site Pruritus 4/13/2008 Male 180 lb 6/13/2008 United States
Primary
Concomitant
Injection Site Haemorrhage 5/18/2008 Female 134 lb 6/13/2008 Physician United States
Primary
Concomitant
Tooth Infection 5/6/2008 Male 165 lb 6/13/2008 United States
Primary
Concomitant
Accidental Exposure 5/23/2008 Male 248 lb 6/13/2008 Consumer United States
Primary
Concomitant
Accidental Exposure 5/29/2008 Male 246 lb 6/13/2008 United States
Primary
Concomitant
Blood Glucose Abnormal Other Serious Female 9/5/2008 Belgium
Primary
Concomitant
Joint Swelling Female 157 lb 9/12/2008 United States
Primary
Concomitant
White Blood Cell Count Increased Female 9/12/2008 Consumer United States
Primary
Concomitant
Unevaluable Event 4/1/2008 Female 147 lb 9/12/2008 United States
Primary
Concomitant
Coronary Arterial Stent Insertion Hospitalization 5/2/2008 Female 246 lb 9/12/2008 Other Health Professional
Primary
Concomitant
Pruritus 7/1/2008 Male 206 lb 9/12/2008 Consumer United States
Primary
Concomitant
Injection Site Swelling 8/4/2008 Male 183 lb 9/12/2008 United States
Primary
Concomitant
Squamous Cell Carcinoma 7/1/2008 Female 150 lb 9/12/2008 Physician United States
Primary
Concomitant
Weight Decreased 6/1/2008 Male 193 lb 9/13/2008 Consumer United States
Primary
Concomitant
Injection Site Pain 8/1/2007 Male 212 lb 9/13/2008 United States
Primary
Concomitant
Injection Site Reaction 6/1/2008 Male 228 lb 9/13/2008 Consumer United States
Primary
Concomitant
Accidental Exposure 8/23/2008 Female 352 lb 9/13/2008 Consumer United States
Primary
Concomitant
Soft Tissue Injury Hospitalization 12/1/2007 Female 9/17/2008 Consumer United States
Primary
Concomitant
Peripheral Vascular Disorder Other Serious 5/2/2008 Female 246 lb 9/23/2008 Physician United States
Primary
Concomitant
Crohn's Disease Hospitalization 9/5/2008 Female 150 lb 9/29/2008 Canada
Primary
Concomitant
Blood Glucose Abnormal Female 11/25/2008 Belgium
Primary
Concomitant
Transmission Of An Infectious Agent Via A Medicinal Product Other Serious 2/1/2008 Male 11/26/2008 Physician United States
Primary
Secondary
Concomitant
Weight Decreased 6/1/2008 Male 193 lb 12/12/2008 Consumer United States
Primary
Concomitant
Accidental Exposure 8/21/2008 Male 230 lb 12/12/2008 Consumer United States
Primary
Concomitant
Poor Quality Sleep 9/3/2008 Female 12/12/2008 Consumer United States
Primary
Concomitant
Rash 7/1/2008 Female 148 lb 12/12/2008 United States
Primary
Concomitant
Injection Site Irritation 5/1/2008 Male 170 lb 12/12/2008 Consumer United States
Primary
Concomitant
Localised Infection 9/4/2008 Female 160 lb 12/12/2008 United States
Primary
Concomitant
Drug Ineffective Male 225 lb 12/12/2008 United States
Primary
Concomitant
Sinusitis 4/1/2008 Female 210 lb 12/12/2008 United States
Primary
Concomitant
Injection Site Pain 10/1/2008 Male 321 lb 12/12/2008 Physician United States
Primary
Concomitant
Injection Site Reaction 10/15/2008 Female 12/12/2008 United States
Primary
Concomitant
Sputum Normal 10/1/2008 Female 12/12/2008 Consumer United States
Primary
Concomitant
Sinusitis 10/1/2008 Female 141 lb 12/12/2008 Consumer United States
Primary
Concomitant
Injection Site Irritation 7/1/2008 Male 12/12/2008 Physician United States
Primary
Concomitant
Sinus Congestion 1/1/2007 Female 12/12/2008 Consumer United States
Primary
Concomitant
Hyperhidrosis 6/1/2008 Female 156 lb 12/12/2008 United States
Primary
Concomitant
Injection Site Haemorrhage 11/17/2008 Female 170 lb 12/12/2008 Consumer United States
Primary
Concomitant
Drug Ineffective 1/1/2007 Male 12/12/2008 United States
Primary
Concomitant
Injection Site Irritation 1/1/2005 Female 170 lb 12/12/2008 Consumer United States
Primary
Concomitant
Metastasis Death Female 149 lb 12/16/2008
Primary
Concomitant
Respiratory Disorder Other Serious Female 12/30/2008 Belgium
Primary
Concomitant
Crohn's Disease Hospitalization 9/5/2008 Female 150 lb 1/9/2009 Canada
Primary
Concomitant
Urinary Retention Other Serious 1/3/2008 Male 2/19/2009 Physician United States
Primary
Secondary
Concomitant
Injection Site Pain 1/1/2008 215 lb 3/14/2009 Consumer United States
Primary
Concomitant
Urinary Retention Other Serious 1/3/2008 Male 4/14/2009 Physician United States
Primary
Secondary
Concomitant
Injection Site Pain 8/1/2008 Male 252 lb 6/12/2009 Consumer United States
Primary
Concomitant
Vision Blurred Female 170 lb 6/12/2009 Physician United States
Primary
Concomitant
Pancreatitis Acute Hospitalization 6/14/2009 40 Male 262 lb 7/27/2009 Other Health Professional United Kingdom
Primary
Concomitant
Pancreatitis Acute Hospitalization 6/14/2009 Male 291 lb 8/13/2009 Other Health Professional United Kingdom
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 7/21/2009 Female 92 lb 9/4/2009 Japan
Primary
Secondary
Concomitant
Incorrect Dose Administered 11/30/2006 Male 176 lb 9/11/2009 Consumer United States
Primary
Concomitant
Incorrect Dose Administered 6/13/2007 Female 170 lb 9/11/2009 Consumer United States
Primary
Concomitant
Wrong Technique In Drug Usage Process 8/1/2007 Female 150 lb 9/12/2009 Consumer United States
Primary
Concomitant
Drug Delivery System Malfunction 5/23/2008 Male 248 lb 9/12/2009 Consumer United States
Primary
Concomitant
Injection Site Haemorrhage 5/18/2008 Female 134 lb 9/12/2009 Physician United States
Primary
Concomitant
Wrong Technique In Drug Usage Process 5/29/2008 Male 246 lb 9/12/2009 United States
Primary
Concomitant
Poor Quality Sleep 9/3/2008 Female 9/12/2009 Consumer United States
Primary
Concomitant
Drug Delivery System Malfunction 8/21/2008 Male 230 lb 9/12/2009 Consumer United States
Primary
Concomitant
Drug Delivery System Malfunction 8/23/2008 Female 352 lb 9/12/2009 Consumer United States
Primary
Concomitant
Wrong Technique In Drug Usage Process 10/1/2008 Male 321 lb 9/12/2009 Physician United States
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 7/21/2009 Female 92 lb 9/17/2009 Japan
Primary
Secondary
Concomitant
Vision Blurred Hospitalization Female 151 lb 12/9/2009 Consumer
Primary
Concomitant
Fluid Retention 8/1/2009 Male 200 lb 1/29/2010 Physician
Primary
Concomitant
Oedema Peripheral 12/23/2009 Male 212 lb 1/30/2010 United States
Primary
Concomitant
Pyrexia Other Serious 1/1/2009 Female 3/1/2010 Canada
Primary
Concomitant
Pyrexia Other Serious 1/1/2009 Female 3/2/2010 Canada
Primary
Concomitant
Skin Discolouration Other Serious 1/1/2009 Female 3/12/2010 Canada
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 7/17/2009 70 Female 92 lb 7/8/2010 Physician Japan
Primary
Secondary
Concomitant
Osteoporotic Fracture Hospitalization 3/1/2010 81 Female 172 lb 8/11/2010 Physician Belgium
Primary
Concomitant
Prostate Cancer Metastatic Other Serious 4/14/2009 63 Male 249 lb 8/17/2010 Physician France
Primary
Concomitant
Osteoporotic Fracture Hospitalization 3/1/2010 81 Female 172 lb 8/17/2010 Physician Belgium
Primary
Concomitant
Vomiting Hospitalization 4/1/2010 50 Female 9/9/2010 Consumer United States
Primary
Secondary
Concomitant
Vomiting Hospitalization 4/1/2010 50 Female 9/13/2010 Consumer United States
Primary
Secondary
Concomitant
Red Blood Cell Count Decreased Other Serious 6/1/2010 61 Male 189 lb 12/16/2010 Consumer United States
Primary
Secondary
Concomitant
Red Blood Cell Count Decreased Other Serious 6/1/2010 61 Male 189 lb 12/17/2010 Consumer United States
Primary
Secondary
Concomitant
Exostosis Hospitalization 9/15/2010 50 Male 175 lb 12/27/2010 Consumer United States
Primary
Concomitant
Visual Acuity Reduced Hospitalization 1/1/2010 55 Female 140 lb 1/24/2011 Consumer United States
Primary
Secondary
Concomitant
Overgrowth Bacterial Other Serious 1/1/2010 53 Male 215 lb 1/26/2011 Consumer United States
Primary
Secondary
Concomitant
Dyspnoea Hospitalization 1/1/2010 55 Female 140 lb 1/26/2011 Physician
Primary
Secondary
Concomitant
Psoriasis 3/1/2010 55 Female 260 lb 1/28/2011 Consumer United States
Primary
Concomitant
Drug Ineffective Female 145 lb 1/28/2011 Physician
Primary
Concomitant
Rotator Cuff Syndrome 1/1/2008 66 Male 1/28/2011 Consumer United States
Primary
Concomitant
Dyspnoea Hospitalization 12/1/2009 74 Female 1/28/2011 Consumer United States
Primary
Concomitant
Injection Site Pain Female 124 lb 1/28/2011 Consumer United States
Primary
Concomitant
Headache Male 200 lb 1/29/2011 Consumer United States
Primary
Concomitant
Arthralgia 1/1/2008 60 Male 243 lb 1/29/2011 Consumer United States
Primary
Concomitant
Injection Site Pain Hospitalization 1/1/2006 59 Female 196 lb 1/29/2011 Consumer United States
Primary
Concomitant
Pain Male 188 lb 1/30/2011 Consumer United States
Primary
Concomitant
Skin Exfoliation 7/1/2010 67 Female 1/30/2011 Consumer United States
Primary
Concomitant
Arthralgia 1/1/2008 65 Male 220 lb 1/30/2011 Consumer United States
Primary
Concomitant
Injection Site Pain 6/1/2010 51 Male 295 lb 1/30/2011 Consumer United States
Primary
Concomitant
Injection Site Haemorrhage 9/25/2010 74 Male 1/30/2011 Consumer United States
Primary
Concomitant
Drug Ineffective Female 100 lb 1/30/2011 Consumer United States
Primary
Concomitant
Basal Cell Carcinoma Other Serious 6/1/2009 68 Male 180 lb 1/30/2011 Consumer United States
Primary
Concomitant
Visual Acuity Reduced Other Serious 11/1/2010 38 Female 3/30/2011 Consumer United States
Primary
Concomitant

Drug Data